Advertisement

Topics

Human Immunodeficiency Virus HIV Infections AIDS Pipeline Review, H1 2017 [Report Updated: 30062017] Prices from USD $2500

10:29 EDT 5 Jul 2017 | BioPortfolio Report Blog

Human Immunodeficiency Virus HIV Infections AIDS Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Immunodeficiency Virus HIV Infections AIDS Pipeline Review, H1 2017, provides an overview of the Human Immunodeficiency Virus HIV Infections AIDS Infectious Disease pipeline landscape.

HIV is a virus which attacks the immune system, and weakens ability to fight infections and disease. Symptoms include fever, sore throat, body rash, joint pain, muscle pain and swollen glands. The most common ways HIV is spread are by having vaginal or anal intercourse without a condom with someone who has HIV/AIDS, sharing needles or syringes with someone who has HIV/AIDS, being deeply punctured with a needle or surgical instrument contaminated with HIV and getting HIVinfected blood, semen, or vaginal secretions into open wounds or sores.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Human Immunodeficiency Virus HIV Infections AIDS Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Human Immunodeficiency Virus HIV Infections AIDS Infectious Disease, complete with analysis by stage of development, drug target, mechanism of action MoA, route of administration RoA and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Human Immunodeficiency Virus HIV Infections AIDS Infectious Disease pipeline guide also reviews of key players involved in therapeutic development for Human Immunodeficiency Virus HIV Infections AIDS and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in PreRegistration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 6, 1, 16, 46, 37, 1, 4, 114, 75 and 6 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 2, 17, 15, 57 and 66 molecules, respectively.

Human Immunodeficiency Virus HIV Infections AIDS Infectious Disease pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Human Immunodeficiency Virus HIV Infections AIDS Infectious Disease.
The pipeline guide reviews pipeline therapeutics for Human Immunodeficiency Virus HIV Infections AIDS Infectious Disease by companies and universities/research institutes based on information derived from company and industryspecific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from preregistration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, RD brief, MoA other developmental activities.
The pipeline guide reviews key companies involved in Human Immunodeficiency Virus HIV Infections AIDS Infectious Disease therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Human Immunodeficiency Virus HIV Infections AIDS Infectious Disease therapeutics based on mechanism of action MoA, drug target, route of administration RoA and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Human Immunodeficiency Virus HIV Infections AIDS Infectious Disease

Reasons to buy

Procure strategically important competitor information, analysis, and insights to formulate effective RD strategies.
Recognize emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.
Find and recognize significant and varied types of therapeutics under development for Human Immunodeficiency Virus HIV Infections AIDS Infectious Disease.
Classify potential new clients or partners in the target demographic.
Develop tactical initiatives by understanding the focus areas of leading companies.
Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
Formulate corrective measures for pipeline projects by understanding Human Immunodeficiency Virus HIV Infections AIDS Infectious Disease pipeline depth and focus of Indication therapeutics.
Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the knowhow what drove them from pipeline.

Original Article: Human Immunodeficiency Virus HIV Infections AIDS Pipeline Review, H1 2017 [Report Updated: 30062017] Prices from USD $2500

NEXT ARTICLE

More From BioPortfolio on "Human Immunodeficiency Virus HIV Infections AIDS Pipeline Review, H1 2017 [Report Updated: 30062017] Prices from USD $2500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Human Immuno Deficiency Virus (HIV)
Human Immunodeficiency Virus (HIV), the causative agent of AIDS. The Human Immunodeficiency Virus, more commonly known as HIV, is a member of the lentivirus sub-set of the retrovirus family of pathogens. It causes AIDS, or Acquired Immuno Deficiency Sy...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...